Dermaliq Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Dermaliq Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men (NCT05636904) | Dermaliq Therapeutics, Inc. | 2022-12-05 |
Track Dermaliq Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.